Our top pick for
Beginners
PRA Health Sciences Inc is a diagnostics & research business based in the US. PRA Health Sciences shares (PRAH) are listed on the NASDAQ and all prices are listed in US Dollars. PRA Health Sciences employs 18,100 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in PRA Health Sciences
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PRAH – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
PRA Health Sciences stock price (NASDAQ: PRAH)
Use our graph to track the performance of PRAH stocks over time.PRA Health Sciences shares at a glance
Information last updated 2021-08-29.
| Latest market close | $170.92 |
|---|---|
| 52-week range | $0.00 - $0.00 |
| 50-day moving average | $169.44 |
| 200-day moving average | $149.58 |
| Wall St. target price | $165.40 |
| PE ratio | 50.5229 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $3.27 |
Buy PRA Health Sciences shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 5 of 5
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy PRA Health Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PRA Health Sciences price performance over time
Historical closes compared with the close of $170.92 from 2021-05-28
| 1 week (2022-06-25) | N/A |
|---|---|
| 1 month (2022-06-02) | N/A |
| 3 months (2022-04-02) | N/A |
| 6 months (2022-01-02) | N/A |
| 1 year (2021-07-02) | N/A |
|---|---|
| 2 years (2020-07-06) | 77.95% |
| 3 years (2019-07-05) | 73.26% |
| 5 years (2017-07-06) | 131.44% |
Is PRA Health Sciences stock undervalued or overvalued?
Valuing PRA Health Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PRA Health Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PRA Health Sciences's P/E ratio
PRA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 51x. In other words, PRA Health Sciences shares trade at around 51x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
PRA Health Sciences's PEG ratio
PRA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0426. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PRA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
PRA Health Sciences's EBITDA
PRA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $435.2 million.
The EBITDA is a measure of a PRA Health Sciences's overall financial performance and is widely used to measure a its profitability.
PRA Health Sciences financials
| Revenue TTM | $3.3 billion |
|---|---|
| Operating margin TTM | 9.1% |
| Gross profit TTM | $1.5 billion |
| Return on assets TTM | 4.76% |
| Return on equity TTM | 16.02% |
| Profit margin | 6.4% |
| Book value | $24.03 |
| Market capitalisation | $10.7 billion |
TTM: trailing 12 months
PRA Health Sciences share dividends
We're not expecting PRA Health Sciences to pay a dividend over the next 12 months.
PRA Health Sciences share price volatility
Over the last 12 months, PRA Health Sciences's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PRA Health Sciences's is 1.3272. This would suggest that PRA Health Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
PRA Health Sciences overview
PRA Health Sciences, Inc. , a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. It operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that allow clients to access and analyze Symphony Health and integrated third-party data.
Frequently asked questions
What percentage of PRA Health Sciences is owned by insiders or institutions?Currently 0.231% of PRA Health Sciences shares are held by insiders and 96.628% by institutions. How many people work for PRA Health Sciences?
Latest data suggests 18,100 work at PRA Health Sciences. When does the fiscal year end for PRA Health Sciences?
PRA Health Sciences's fiscal year ends in December. Where is PRA Health Sciences based?
PRA Health Sciences's address is: 4130 ParkLake Avenue, Raleigh, NC, United States, 27612 What is PRA Health Sciences's ISIN number?
PRA Health Sciences's international securities identification number is: US69354M1080 What is PRA Health Sciences's CUSIP number?
PRA Health Sciences's Committee on Uniform Securities Identification Procedures number is: 69354M108
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert